However, all showed a trend toward recovery of kidney function after completion of treatment.
← all excerpts
Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study.
1
—
—